M 1731 Tenofovir diphosphate, tetraammonium salt Click here for Typical Certificate of Analysis |
|
(PMPApp, tetrammonium salt) | |
|
|
Solid | 1 µmol $1465 |
Screw cap v-vial - shipped on dry ice | 6 µmol $3955 |
M.W. 447.17 for free acid | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MG 135 Tenofovir diphosphate, tetraammonium salt, [adenine-13C5]- |
|
(PMPApp, tetraammonium salt, [adenine-13C5]-) | |
|
|
Solid | |
Screw cap v-vial - shipped on dry ice | 2 µmol $1440 |
M.W. 452.14 for free acid | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MT 1893 Tenofovir diphosphate, tetraammonium salt, [adenine-8-3H]- |
|
Click here for Typical Certificate of Analysis | |
(PMPApp, tetraammonium salt, [adenine-8-3H]-) | |
|
|
Ethanol:water (1:1) solution, 1 mCi/ml | |
> 1 Ci(37 GBq)/mmol | 50 µCi (1.85 MBq) $1160 |
NextGen V-Vial - shipped on dry ice | 250 µCi (9.25 MBq) $1970 |
M.W. 447.17 for free acid | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |